Itch in Ethnic Populations

Total Page:16

File Type:pdf, Size:1020Kb

Itch in Ethnic Populations Acta Derm Venereol 2010; 90: 227–234 REVIEW ARTICLE Itch in Ethnic Populations Hong Liang TEY1 and Gil YOSIPOVITCH2 1National Skin Centre, 1, Mandalay Road, Singapore, Singapore, and 2Department of Dermatology, Neurobiology & Anatomy, and Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC, USA Racial and ethnic differences in the prevalence and clini- DIFFERENCES IN SKIN BIOLOGY AND ITCH cal characteristics of itch have rarely been studied. The aim of this review is to highlight possible associations Few studies have examined the differences between between ethnicity and different forms of chronic itch. We skin types in relation to ethnicity and neurobiology of provide a current review of the prevalence of different the skin. Differences between ethnic skin types and types of itch in ethnic populations. Genetic variation may skin properties may explain racial disparities seen in significantly affect receptors for itch as well as response pruritic dermatologic disorders. to anti-pruritic therapies. Primary cutaneous amyloido- sis, a type of pruritic dermatosis, is particularly common Epidermal structure and function in Asians and rare in Caucasians and African Ameri- cans, and this may relate to a genetic polymorphism in A recent study has shown that the skin surface and the Interleukin-31 receptor. Pruritus secondary to the melanocyte cytosol of darkly pigmented skin is more use of chloroquine for malaria is a common problem for acidic compared with those of type I–III skin (1). Serine African patients, but is not commonly reported in other protease enzymes, which have significant roles as pruri- ethnic groups. In patients with primary biliary cirrho- togens in atopic eczema and other chronic skin diseases, sis, pruritus is more common and more severe in African have been shown to be significantly reduced in black Americans and Hispanics compared with Caucasians. skin too, which have significant roles as pruritogens in Racial and ethnic differences in itch and its medical care atopic eczema and other chronic skin diseases (2, 3) and are poorly understood. Research is needed to examine have increased activity in alkaline skin pH (4). Taken biological, psychosocial, and lifestyle factors that may together, these epidermal functional differences could contribute to these disparities. Key words: pruritus; race; explain differences in itch and skin irritation between Black; Asian; Caucasian; Hispanics. different skin types. There have been several studies that indicate that (Accepted March 16, 2010.) Asian skin is more sensitive to exogenous chemicals, and this may be due to a thinner stratum corneum and a Acta Derm Venereol 2010; 90: 227–234. higher density of eccrine glands (5). Japanese cheek skin Gil Yosipovitch, Department of Dermatology, Neurobio- was found to have a greater number of acid-sensing ion logy & Anatomy, and Regenerative Medicine, Wake Forest channels (ASICs) and heightened sensory thresholds in University Health Sciences, Winston-Salem, NC 27157, comparison with Caucasians. This may explain why Ja- USA. E-mail: [email protected] panese women more frequently report itch and burning sensations after application of cosmetic products (6). The prevalence of itch varies significantly across diffe- Skin innervation rent ethnic populations. Several pruritic conditions occur more frequently in certain ethnic groups and in certain To the best of our knowledge, no study has examined diseases. However, the impact of ethnicity on itch has so the differences in the innervation density of the skin far received minimal attention. between African Americans, Hispanics, and other The study of chronic itch is complicated, as it is in- ethnic populations. fluenced by multiple factors, such as age, environment, Microscopic evaluation has revealed that black skin social, cultural, level of education and psychological contains larger mast cell granules compared with white factors. Knowledge of racial differences in pruritic skin, and differences in structural properties and enzy- conditions is useful to aid diagnosis and to provide mes of mast cells have been found (7). However, the appropriate management. This short review summarizes clinical relevance of these findings to itch is unclear. the differences in skin structure and function and its Recently, Wang et al. (8) compared the differences association with itch in different ethnic populations, in sensory response and neurogenic inflammation to and describes itch entities that are specific to different topical capsaicin between four different ethnic popula- ethnic populations. tions: African Americans, East Asians, Hispanics and © 2010 The Authors. doi: 10.2340/00015555-0867 Acta Derm Venereol 90 Journal Compilation © 2010 Acta Dermato-Venereologica. ISSN 0001-5555 228 H. L. Tey and G. Yosipovitch Caucasians. Capsaicin is known to induce initial burning sensation as well as itch and is used in alleviating pain and itch via activation of TRPV1 receptor. African Ame- ricans, in sharp contrast to the three other ethnic groups, demonstrated a lack of hyperalgesia and neurogenic inflammation. Hispanics were the only group to report significant itching after capsaicin application. It would be of interest to examine whether there are any functio- nal genetic polymorphisms in receptors for TRPV1 that may explain these findings. In addition, these prelimi- nary results may suggest that response to anti-pruritic drugs may differ between ethnic populations, similar to reports of differences in response to pain-relieving medications between different races (9, 10). ITCH IN THE GENERAL POPULATION A cross-sectional study was conducted in Norway, which involved postal questionnaire response from 18,770 adults (11). Eighty-four percent of the sample population was Norwegian, 5% was immigrants from Western countries, and 3% was immigrants from the Indian subcontinent. The presence of itch over the past week in respondents was found to be significantly more in men from East Asia (18%) and Middle East/ North Africa (13%) compared with Norwegians (7%). Psychosocial factors, however, are confounding factors as immigrants have different health behaviors and a lower socio-economic status, and these are known to result in increased morbidity (12, 13). On the other Fig. 1. Brown keratotic papules on the shins and calves of a patient with hand, in a pilot study investigating chronic itch in the lichen amyloidosis. general population, the life prevalence of itch in a sample of the German population (n = 200) was found In localized cutaneous amyloidosis, the deposition of to be 22.6% (14). amyloid either occurs along reticulin fibers and the basal membrane (peri-reticulary amyloidoses) or along DERMATOLOGIC ITCH collagen fibers (peri-collagenous amyloidosis) (17). Primary cutaneous amyloidosis has been known to be Pruritus secondary to dermatologic diseases is the more common in certain populations, namely Southeast most common cause of itch, and chronic dermatologic Asians and South Americans (18–21). itch poses significant morbidity. In a German study, Itch is often present in primary localized cutaneous an underlying dermatosis was identified in 42% of amyloidosis, in both the sporadic and hereditary forms. 263 patients with chronic pruritus (15). In a study The prevalence of itch various in different studies: 62% comparing patients with pruritus in Germany and in in Singapore (22), 82% in Saudi Arabia (23), and 90% Uganda, pruritic dermatoses were responsible in 57% in India (24). The lesions of localized cutaneous amy- (75/132) of the cases in Germany (16). In contrast, in loidosis commonly occurs over the upper back, outer the Ugandan population, dermatoses were responsible arms, and the shins and in the study by Salim et al., the for causing itch in 96% (81/84) of the cases. most common site of itch was the shins (24). Several pruritic skin conditions are unique in skin A study compared the skin innervation density of 30 of specific ethnic groups, and some of these will be Hispanic patients with clinico-pathologically proven discussed in more detail below. lichen amyloidosis with 11 healthy Hispanic controls (25). The amount and area covered by nerve fibers in the Primary localized cutaneous amyloidosis epidermis and the dermoepidermal junction were found to be significantly higher in healthy skin compared with Primary localized cutaneous amyloidosis consists of skin affected by lichen amyloidosis. No difference in in- primary macular and lichenoid amyloidosis (Fig. 1). nervation density in the papillary dermis was found. An Acta Derm Venereol 90 Ethnic itch 229 explanation for these findings may be that the pruritus in lichen amyloidosis is due to damage to the nerve fibers. The cause of this damage, however, is not known. Molecular studies have recently opened new insights into the pathogenetic mechanisms of pruritus in familial primary localized cutaneous amyloidosis. It has been proposed that when mutant oncostatin M receptor β present on keratinocytes, cutaneous nerves, and specific neurons in the dorsal root ganglia are stimulated by oncostatin M (OSM) or interleukin-31 (IL-31), signa- ling abnormalities via the OSM type II receptor and/ or the IL-31 receptor leads to keratinocyte apoptosis (with subsequent amyloid deposition), reduced num- ber of cutaneous nerves (from possible apoptosis) and, in most individuals, pruritus (26). Lin et al. (27) subsequently identified a point mutation in the IL-31 receptor A gene in a family with hereditary primary cutaneous
Recommended publications
  • Dermatologia 2021;96(4):397---407
    Anais Brasileiros de Dermatologia 2021;96(4):397---407 Anais Brasileiros de Dermatologia www.anaisdedermatologia.org.br CONTINUING MEDICAL EDUCATION Phototherapyଝ,ଝଝ ∗ Norami de Moura Barros , Lissiê Lunardi Sbroglio , Maria de Oliveira Buffara , Jessica Lana Conceic¸ão e Silva Baka , Allen de Souza Pessoa , Luna Azulay-Abulafia Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil Received 3 December 2019; accepted 2 March 2021 Available online 2 April 2021 Abstract Of all the therapeutic options available in Dermatology, few of them have the his- KEYWORDS tory, effectiveness, and safety of phototherapy. Heliotherapy, NB-UVB, PUVA, and UVA1 are Phototherapy; currently the most common types of phototherapy used. Although psoriasis is the most frequent PUVA therapy; indication, it is used for atopic dermatitis, vitiligo, cutaneous T-cell lymphoma, and cutaneous Ultraviolet therapy sclerosis, among others. Before indicating phototherapy, a complete patient assessment should be performed. Possible contraindications should be actively searched for and it is essential to assess whether the patient can come to the treatment center at least twice a week. One of the main method limitations is the difficulty that patients have to attend the sessions. This therapy usually occurs in association with other treatments: topical or systemic medications. Maintaining the regular monitoring of the patient is essential to identify and treat possible adverse effects. Phototherapy is recognized for its benefits and should be considered whenever possible. © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana,˜ S.L.U. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
    [Show full text]
  • European Guideline Chronic Pruritus Final Version
    EDF-Guidelines for Chronic Pruritus In cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Européenne des Médecins Spécialistes (UEMS) E Weisshaar1, JC Szepietowski2, U Darsow3, L Misery4, J Wallengren5, T Mettang6, U Gieler7, T Lotti8, J Lambert9, P Maisel10, M Streit11, M Greaves12, A Carmichael13, E Tschachler14, J Ring3, S Ständer15 University Hospital Heidelberg, Clinical Social Medicine, Environmental and Occupational Dermatology, Germany1, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Poland2, Department of Dermatology and Allergy Biederstein, Technical University Munich, Germany3, Department of Dermatology, University Hospital Brest, France4, Department of Dermatology, Lund University, Sweden5, German Clinic for Diagnostics, Nephrology, Wiesbaden, Germany6, Department of Psychosomatic Dermatology, Clinic for Psychosomatic Medicine, University of Giessen, Germany7, Department of Dermatology, University of Florence, Italy8, Department of Dermatology, University of Antwerpen, Belgium9, Department of General Medicine, University Hospital Muenster, Germany10, Department of Dermatology, Kantonsspital Aarau, Switzerland11, Department of Dermatology, St. Thomas Hospital Lambeth, London, UK12, Department of Dermatology, James Cook University Hospital Middlesbrough, UK13, Department of Dermatology, Medical University Vienna, Austria14, Department of Dermatology, Competence Center for Pruritus, University Hospital Muenster, Germany15 Corresponding author: Elke Weisshaar
    [Show full text]
  • This PDF Is Available for Free Download from a Site Hosted by Medknow Publications (
    View Point Prurigo pigmentosa: An underdiagnosed disease? A. Böer, M. Asgari* Department of Dermatology and Dermatopathology, Dermatologikum, Hamburg, Germany, *Department of Pathology, Razi Center of Skin Lesions, Tehran University of Medical Sciences, Tehran, Iran. Address for correspondence: Dr. Almut Böer, Dermatologikum Hamburg, Stephansplatz 5, 20354, Hamburg, Germany. E-mail: [email protected] ABSTRACT Prurigo pigmentosa is a distinctive inflammatory disease first described by the Japanese dermatologist Masaji Nagashima in 1971. It is typified by recurrent, pruritic erythematous macules, papules and papulovesicles that resolve leaving behind netlike pigmentation. The disease is rarely diagnosed outside Japan, because clinicians outside Japan are not well conversant with the criteria for its diagnosis. Only one patient from India has been published previously under the diagnosis of prurigo pigmentosa, a hint that the disease may be under-recognized in India. We present an account of our observations in patients diagnosed with prurigo pigmentosa who were of five different nationalities, namely, Japanese, German, Indonesian, Turkish and Iranian. With this article we seek to increase awareness for the condition among dermatologists in India and we provide criteria for its diagnosis, both clinically and histopathologically. .com). Key Words: India, Pigmentation, Pruritic exanthema, Prurigo pigmentosa, Reticulate hyperpigmentation INTRODUCTION patient who presented with recurrent episodes of .medknowreticulate papular rash that resolved
    [Show full text]
  • Update of the Guideline on Chronic Pruritus
    Update of the Guideline on Chronic Pruritus Developed by the Guideline Subcommittee “Chronic Pruritus” of the European Dermatology Forum Subcommittee Members: Prof. Dr. Elke Weisshaar, Heidelberg (Germany) Prof. Dr. Sonja Ständer, Münster (Germany) Prof. Dr. Erwin Tschachler, Wien (Austria) Prof. Dr. Torello Lotti, Florence (Italy) Prof. Dr. Johannes Ring, Munich (Germany) Prof. Dr. Laurent Misery, Brest (France) Dr. Markus Streit, Aarau (Switzerland) Prof. Dr. Thomas Mettang, Wiesbaden (Germany) Prof. Dr. Jacek Szepietowski, Wroclaw (Poland) Prof. Dr. Joanna Wallengren, Lund (Sweden) Dr. Peter Maisel, Münster (Germany) Prof. Dr. Uwe Gieler, Gießen (Germany) Prof. Dr. Malcolm Greaves (Singapore) Prof. Dr. Ulf Darsow, Munich (Germany) Prof. Dr. Julien Lambert, Antwerp (Belgium) Members of EDF Guideline Committee: Prof. Dr. Werner Aberer, Graz (Austria) Prof. Dr. Dieter Metze, Münster (Germany) Prof. Dr. Martine Bagot, Paris (France) Dr. Kai Munte, Rotterdam (Netherlands) Prof. Dr. Nicole Basset-Seguin, Paris (France) Prof. Dr. Gilian Murphy, Dublin (Ireland) Prof. Dr. Ulrike Blume-Peytavi, Berlin (Germany) Prof. Dr. Martino Neumann, Rotterdam (Netherlands) Prof. Dr. Lasse Braathen, Bern (Switzerland) Prof. Dr. Tony Ormerod, Aberdeen (UK) Prof. Dr. Sergio Chimenti, Rome (Italy) Prof. Dr. Mauro Picardo, Rome (Italy) Prof. Dr. Alexander Enk, Heidelberg (Germany) Prof. Dr. Johannes Ring, Munich (Germany) Prof. Dr. Claudio Feliciani, Rome (Italy) Prof. Dr. Annamari Ranki, Helsinki (Finland) Prof. Dr. Claus Garbe, Tübingen (Germany) Prof. Dr. Berthold Rzany, Berlin (Germany) Prof. Dr. Harald Gollnick, Magdeburg (Germany) Prof. Dr. Rudolf Stadler, Minden (Germany) Prof. Dr. Gerd Gross, Rostock (Germany) Prof. Dr. Sonja Ständer, Münster (Germany) Prof. Dr. Vladimir Hegyi, Bratislava (Slovakia) Prof. Dr. Eggert Stockfleth, Berlin (Germany) Prof. Dr.
    [Show full text]
  • World Journal of Dermatology
    World Journal of W J D Dermatology Submit a Manuscript: http://www.wjgnet.com/esps/ World J Dermatol 2015 May 2; 4(2): 108-113 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 2218-6190 (online) DOI: 10.5314/wjd.v4.i2.108 © 2015 Baishideng Publishing Group Inc. All rights reserved.V MINIREVIEWS New innovation of moisturizers containing non-steroidal anti-inflammatory agents for atopic dermatitis Montree Udompataikul Montree Udompataikul, Skin Center, Srinakharinwirot experience. These moisturizers might be considered University, Bangkok 10110, Thailand as an alternative treatment in acute flare of mild to Author contributions: Udompataikul M contributed to this moderate atopic dermatitis. work. Conflict-of-interest:None. Key words: Non-steroidal anti-inflammatory agents; Open-Access: This article is an open-access article which was Moisturizer; Atopic dermatitis selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, © The Author(s) 2015. Published by Baishideng Publishing which permits others to distribute, remix, adapt, build upon this Group Inc. All rights reserved. work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and Core tip: The skin care management particular moisturizers the use is non-commercial. See: http://creativecommons.org/ play an important role in atopic dermatitis. The side effects licenses/by-nc/4.0/ of corticosteroids are limited in their use in this disease. Correspondence to: Montree Udompataikul, MD, Associate Take together, a new moisturizer containing various anti- Prefessor, Skin Center, Srinakharinwirot University, Sukhumvit 23, Wattana, Bangkok 10110, Thailand.
    [Show full text]
  • An Underdiagnosed Skin Disease in Malaysia Goh SW, Adawiyah J, Md Nor N, Yap FBB, Ch’Ng PWB,Chang CC Goh SW, Adawiyah J, Md Nor N, Et Al
    CASE REPORT Skin eruption induced by dieting – an underdiagnosed skin disease in Malaysia Goh SW, Adawiyah J, Md Nor N, Yap FBB, Ch’ng PWB,Chang CC Goh SW, Adawiyah J, Md Nor N, et al. Skin eruption induced by dieting – an underdiagnosed skin disease in Malaysia. Malays Fam Physician. 2019;14(1);42–46. Abstract Keywords: Ketogenic diet, weight loss, Prurigo pigmentosa is an inflammatory dermatosis characterized by a pruritic, symmetrically ketosis, Malaysia, prurigo distributed erythematous papular or papulo-vesicular eruption on the trunk arranged in a reticulated pigmentosa pattern that resolves with hyperpigmentation. It is typically non-responsive to topical or systemic steroid therapy. The exact etiology is unknown, but it is more commonly described in the Far East countries. Dietary change is one of the predisposing factors. We report on nine young adult Authors: patients with prurigo pigmentosa, among whom five were on ketogenic diets prior to the onset of the eruptions. All cases resolved with oral doxycycline with no recurrence. We hope to improve the Adawiyah Jamil awareness of this uncommon skin condition among general practitioners and physicians so that (Corresponding author) disfiguring hyperpigmentation due to delayed diagnosis and treatment can be avoided. MB BCh BAO, MMed (UKM) AdvMDerm (UKM) Introduction and 2017 and were reviewed retrospectively. University Kebangsaan Malaysia Consent for photography was obtained from Medical Centre, Kuala Lumpur Prurigo pigmentosa is an inflammatory all patients. Diagnosis of prurigo pigmentosa Malaysia. dermatosis first described by Nagashima in was based on clinicopathological findings Email: [email protected] 14 Japanese patients in 1978.1 The condition from the adapted criteria set by Boer et al.10,11 was quite rare until the last decade, when The duration of follow up ranged from 3 to increasingly more cases were documented, 30 months.
    [Show full text]
  • Pruritus Associated with Chronic Kidney Disease: a Comprehensive Literature Review
    Open Access Review Article DOI: 10.7759/cureus.5256 Pruritus Associated With Chronic Kidney Disease: A Comprehensive Literature Review Sanzida S. Swarna 1 , Kashif Aziz 2 , Tayyaba Zubair 3 , Nida Qadir 4 , Mehreen Khan 5 1. Internal Medicine, Sir Salimullah Medical College, Dhaka, BGD 2. Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA 3. Internal Medicine, Desai Medical Center, Ellicott City, MD, USA 4. Internal Medicine, Liaquat University of Medical and Health Sciences, Liaquat University Hospital Jamshoro, Hyderabad, PAK 5. Internal Medicine, George Washington University School of Medicine and Health Sciences, Washington DC, USA Corresponding author: Kashif Aziz, [email protected] Abstract The prevalence of pruritus in chronic kidney disease (CKD) patients has varied over the years, and some studies suggest the prevalence may be coming down with more effective dialysis. Chronic kidney disease- associated pruritus (CKD-aP), previously called uremic pruritus, is a distressing symptom experienced by patients with mainly advanced chronic kidney disease. CKD-aP is associated with poor quality of life, depression, anxiety, sleep disturbance, and increased mortality. The incidence of CKD-aP is decreasing given improvements in dialysis treatments, but approximately 40% of patients with end-stage renal disease experience CKD-aP. While the pathogenesis of CKD-aP is not well understood, the interaction between non- myelinated C fibers and dermal mast cells plays an important role in precipitation and sensory stimulation. Other causes of CKD-aP include metabolic abnormalities such as abnormal serum calcium, parathyroid, and phosphate levels; an imbalance in opiate receptors is also an important factor. CKD-aP usually presents as large symmetric reddened areas of skin, often at night.
    [Show full text]
  • Cohen, PR: Terra Firma-Forme Dermatosis of the Inguinal Fold
    Open Journal of Clinical & Medical Volume 1 (2015) Issue 4 Case Reports ISSN 2379-1039 Terra Firma-Forme Dermatosis Of The Inguinal Fold: Duncan's Dirty Dermatosis Mimicking Groin Dermatoses *Philip R. Cohen, MD Department of Dermatology, University of California San Diego, San Diego, California Email: [email protected] Abstract Terra irma-forme dermatosis is a benign acquired condition. It is also known as Duncan's dirty dermatosis. It occurs in men and women of all ages. The condition appears to have a male predilection and to occur at concave site, lexor surfaces and skin folds in older individuals. A 70-year-old man with terra irma-forme dermatosis affecting his inguinal folds is described. Woods lamp examination was negative for coral orange to pink coloration. Potassium hydroxide preparation was negative for hyphae and pseudohyphae. The diagnosis of terra irma-forme dermatosis was established by removal of the skin lesions after vigorously rubbing them with 70% isopropyl alcohol. When terra irma-forme dermatosis occurs in the inguinal folds, it can mimic other groin conditions such as erythrasma (Wood's lamp positive for coral orange or pink), intertrigo (potassium hydroxide preparation positive for pseudohyphae) and tinea cruris (potassium hydroxide preparation positive for hyphae). When the diagnosis of terra irma-forme dermatosis is suspected,rubbing the affected area with 70% isopropyl alcohol and witnessing the resolution of the lesions can readily conirm it. Keywords Candidiasis, Duncan's dirty dermatosis, Erythrasma, Groin, Inguinal fold, Intertrigo, Isopropyl alcohol, Terra irma-forme dermatosis, Tinea cruris Introduction Terra irma-forme dermatosis presents as dirty appearing plaques in men and women of all ages [1-4].
    [Show full text]
  • Views in Allergy and Immunology
    CLINICAL REVIEWS IN ALLERGY AND IMMUNOLOGY Dermatology for the Allergist Dennis Kim, MD, and Richard Lockey, MD specific laboratory tests and pathognomonic skin findings do Abstract: Allergists/immunologists see patients with a variety of not exist (Table 1). skin disorders. Some, such as atopic and allergic contact dermatitis, There are 3 forms of AD: acute, subacute, and chronic. are caused by abnormal immunologic reactions, whereas others, Acute AD is characterized by intensely pruritic, erythematous such as seborrheic dermatitis or rosacea, lack an immunologic basis. papules associated with excoriations, vesiculations, and se- This review summarizes a select group of dermatologic problems rous exudates. Subacute AD is associated with erythematous, commonly encountered by an allergist/immunologist. excoriated, scaling papules. Chronic AD is associated with Key Words: dermatology, dermatitis, allergy, allergic, allergist, thickened lichenified skin and fibrotic papules. There is skin, disease considerable overlap of these 3 forms, especially with chronic (WAO Journal 2010; 3:202–215) AD, which can manifest in all 3 ways in the same patient. The relationship between AD and causative allergens is difficult to establish. However, clinical studies suggest that extrinsic factors can impact the course of disease. Therefore, in some cases, it is helpful to perform skin testing on foods INTRODUCTION that are commonly associated with food allergy (wheat, milk, llergists/immunologists see patients with a variety of skin soy, egg, peanut, tree nuts, molluscan, and crustaceous shell- Adisorders. Some, such as atopic and allergic contact fish) and aeroallergens to rule out allergic triggers that can dermatitis, are caused by abnormal immunologic reactions, sometimes exacerbate this disease.
    [Show full text]
  • Epidemiology of Itch: Adding to the Burden of Skin Morbidity
    Acta Derm Venereol 2009; 89: 339–350 REVIEW ARTICLE Epidemiology of Itch: Adding to the Burden of Skin Morbidity Elke WEISSHAAR1 and Florence DALGARD2 1Department of Clinical Social Medicine, Occupational and Environmental Dermatology, University Hospital Heidelberg, Germany, 2Institute of General Practice and Community Medicine, University of Oslo, Norway, and Judge Baker Children Center, Harvard Medical School, Boston, MA, USA Itch is the most frequent symptom in dermatology and disease with environmental factors, to meet demand has been researched more extensively in recent years. and to investigate factors of importance in preventing Nevertheless, there are few true epidemiological studies disease in the population (2–4). Individuals presenting on itch. The aim of this paper is to review the current to doctors tend to have more severe disease, thus this state of research on the epidemiology of chronic itch in patient population represents the tip of the iceberg re- Western and non-Western populations. The electronic lative to ill-health at the community level (3, 5). databases PubMed, Medline and the Cochrane Library The aim of this paper is to review current knowledge were searched. Conference proceedings and national and of the distribution of chronic itch in different popula- international studies were included. It is difficult to com- tions. The electronic databases PubMed, Medline and pare existing studies due to differing methodology and the Cochrane Library were searched. The search terms lack of standardized measures. The symptom of itch is used were: itch, itching, and pruritus, plus all of these a challenge, not only to clinicians, but also within the terms in combination with dermatology, epidemiology, structure of regional health systems, and with regards community, psycho-social factors, and skin diseases.
    [Show full text]
  • A Case of Prurigo Caused by Hair Dye Con- Taining P-Phenylenediamine: Histopatho- Figure 1
    1. Brownstone ND, Thibodeaux QG, Reddy VD, et al. Novel coron- A BC avirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times. Dermatol Ther (Heidelb) 2020; 10: 1-11. 2. Lebwohl M, Rivera-Oyola R, Murrell DF. Should biologics for pso- riasis be interrupted in the era of COVID-19? J Am Acad Dermatol 2020; 82: 1217-8. 3. https://www.santepubliquefrance.fr/maladies-et-traumatismes/ maladies-et-infections-respiratoires/infection-a-coronavirus/articles/ infection-au-nouveau-coronavirus-sars-cov-2-covid-19-france-et-monde. 4. Carugno A, Gambini DM, Raponi F, et al. COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy. J Am Acad Dermatol 2020; 83: 292-4. 5. Burlando M, Carmisciano L, Cozzani E, Parodi A. A survey D EF of psoriasis patients on biologics during COVID-19: a single cen- tre experience. J Dermatolog Treat 2020. Ahead of print. doi: 10.1080/09546634.2020.1770165. 6. Damiani G, Pacifico A, Bragazzi NL, Malagoli P. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admis- sion and death: real-life data from a large cohort during red-zone declaration. Dermatol Ther 2020: e13475. G HI 7. Gisondi P, Facheris P, Dapavo P, et al. The impact of the COVID- 19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol 2020; 183: 373-4. 8. Fougerousse AC, Perrussel M, Bécherel PA, et al. Systemic or bio- logic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
    [Show full text]
  • Emerging Research in Chronic Pruritus: from Bedside to Bench and Back Again
    medicines Editorial Emerging Research in Chronic Pruritus: From Bedside to Bench and Back Again Kyle A. Williams and Shawn G. Kwatra * Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-410-955-5933 Received: 21 April 2020; Accepted: 26 April 2020; Published: 29 April 2020 Abstract: This Medicines special issue highlights emerging research spanning from epidemiology to diagnostic workup, pathogenesis, and therapeutics for patients suffering from chronic pruritus. The special issue contains 13 articles reporting relevant epidemiologic and experimental data on chronic pruritus. Keywords: pruritus; itch; treatment; therapeutic; pathogenesis; epidemiology 1. Introduction This editorial serves as an introduction to the special issue “Pathogenesis and Treatment of Chronic Pruritus” and contains an overview of various known causes of chronic pruritus and emerging therapeutics. Chronic pruritus is itch that lasts greater than six weeks and is associated with a variety of dermatologic, systemic, neurologic, and psychiatric etiologies. Itch negatively impacts patient quality of life and has devastating psychosocial consequences. The manuscripts published in this special issue are also a showcase of the current understanding of the pathogenesis of chronic pruritus, along with its epidemiology, diagnostic workup, and therapeutic approaches used to treat chronic pruritus. 2. Epidemiology Chronic pruritus can arise in association with many disease processes and affects many patient populations. Thus, epidemiologic studies are needed to gain a better understanding of the burden of disease. In this special issue, a cross-sectional study of over 18,000 itch patients seen at a tertiary care center showed that African American and female patients were more likely to experience pruritus than their white or male counterparts [1].
    [Show full text]